GLP-1 drugs could become personalized for individuals, study says
The higher-dosage GLP-1 agonists largely engendered greater cardiometabolic improvements. |!| Indianapolis
The higher-dosage GLP-1 agonists largely engendered greater cardiometabolic improvements. |!| Indianapolis